Jupiter Neurosciences, Inc.
JUNS
$1.21
$0.032.54%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 816.70K | 759.40K | 466.70K | 201.00K | 91.90K |
| Gross Profit | -816.70K | -759.40K | -466.70K | -201.00K | -91.90K |
| SG&A Expenses | 1.48M | 1.51M | 1.07M | 1.26M | 401.60K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.30M | 2.26M | 1.54M | 1.46M | 493.50K |
| Operating Income | -2.30M | -2.26M | -1.54M | -1.46M | -493.50K |
| Income Before Tax | -2.29M | -2.25M | -1.53M | -1.53M | -591.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.29M | -2.25M | -1.53M | -1.53M | -591.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.29M | -2.25M | -1.53M | -1.53M | -591.00K |
| EBIT | -2.30M | -2.26M | -1.54M | -1.46M | -493.50K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.07 | -0.07 | -0.05 | -0.05 | -0.02 |
| Normalized Basic EPS | -0.04 | -0.04 | -0.03 | -0.03 | -0.01 |
| EPS Diluted | -0.07 | -0.07 | -0.05 | -0.05 | -0.02 |
| Normalized Diluted EPS | -0.04 | -0.04 | -0.03 | -0.03 | -0.01 |
| Average Basic Shares Outstanding | 34.04M | 33.18M | 33.10M | 31.64M | 31.07M |
| Average Diluted Shares Outstanding | 34.04M | 33.18M | 33.10M | 31.64M | 31.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |